Sasakawa-India Leprosy Foundation appoints Dr Vivek Lal as CEO

Dr Vivek Lal who has joined as the new Chief Executive Officer of Sasakawa-India Leprosy Foundation (S-ILF), an organization that works for the socio-economic development of persons affected by leprosy and their families

0
66
New Delhi: Sasakawa-India Leprosy Foundation (S-ILF), an organization working for the socio-economic development of persons affected by leprosy and their families has announced the appointment of  Dr Vivek Lal as their new CEO. During the momentous journey that has clocked more than a decade, S-ILF has relentlessly worked towards mainstreaming persons affected by leprosy and their families through socio-economic empowerment. 
Commenting on this appointment, Mr Tarun Das, Chairman S-ILF said, “We are proud to have Dr Vivek Lal as the CEO of our Foundation. I am confident that with his enthusiasm and experience in the field of leprosy, he will drive the organization to new heights. During this global pandemic, Vivek’s experience in humanitarian services will be of great help in reaching out to the most vulnerable members of the society – the leprosy-affected population residing in secluded leprosy colonies.”
Dr Lal is a medical practitioner with a specialization in Community Medicine from AIIMS, Delhi. He has several years of experience working in the field of leprosy and humanitarian services and has earlier worked as Director Health at German Leprosy and TB Relief Association.
“I am excited to be a part of S-ILF. A holistic approach incorporating both medical and social supports for persons affected by leprosy and their families along with an enabling environment brought in through awareness generation among the community are the biggest weapons in our fight against leprosy. I look forward to being a part of this journey: a constant pursuit to restore dignity in their lives”, said Dr Vivek Lal.